Price $11.73 |
Market Cap
448.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.26
|
P/S
0.64
|
Dividend %
-
|
|
P/CF
10.4
|
P/FCF
2.8
|
Op. Cash Flow
176.3K
|
FCF
3.9
|
|
Op. Margin
-40.10%
|
Net Margin
-41.50%
|
ROE
-83.00%
|
ROI
-17.70%
|
|
ROA
-21.80%
|
EPS Growth
-
|
Current Ratio
2.7
|
Debt/Equity
198.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| United Therapeutics Corporatio (UTHR) | $82.14 | - | - | 3.6B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.68 | - | - | 13.8M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $1.43 | - | - | 5.5M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $1.17 | - | - | 92.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 11.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
